| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Ashlins schließt Lizenzabkommen mit Lee's Pharm für Interferon-Wirkstoff | 2 | Investing.com Deutsch | ||
| 17.07. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - ENTERING INTO EXCLUSIVE LICENSE-OUT AND SUPPLY AGREEMENT WITH ASHLINS FOR INTERFERON ALPHA-2B PRODUCTS ... | 1 | HKEx | ||
| 16.06. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE PROGRAM UNDER THE REPURCHASE MANDATE | 1 | HKEx | ||
| 01.06. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - FUNDING APPROVED FOR SYNTHETIC SURFACTANT PROJECT | 1 | HKEx | ||
| 27.05. | Dividendenbekanntmachungen (27.05.2026) | 8.401 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAC TECHNOLOGIES HOLDINGS INC ADR US0003041052 0,0446 USD 0,0384 EUR ADVANCE TERRAFUND REIT BG1100025052 - 0,065 EUR APOTEA AB SE0023313762 0... ► Artikel lesen | |
| LEES PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 21.05. | LEE'S PHARM (00950): ANNUAL GENERAL MEETING HELD ON 21 MAY 2026 - POLL RESULTS | 1 | HKEx | ||
| 11.05. | LEE'S PHARM (00950): CONNECTED TRANSACTION - INVESTMENT IN PARTNERSHIP FUND | 1 | HKEx | ||
| 24.04. | LEE'S PHARM (00950): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
| 24.04. | LEE'S PHARM (00950): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | 2 | HKEx | ||
| 23.04. | LEE'S PHARM (00950): PROXY FORM | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | 1 | HKEx | ||
| 23.04. | LEE'S PHARM (00950): ANNUAL REPORT 2025 | - | HKEx | ||
| 30.03. | LEE'S PHARM (00950): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 | 1 | HKEx | ||
| 30.03. | Lee's Pharmaceutical Holdings Ltd. Reports Retreat In Full Year Bottom Line | 1 | RTTNews | ||
| 30.03. | LEE'S PHARM (00950): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 | - | HKEx | ||
| 25.03. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - APPROVAL OF INTRAROSA BY NMPA | - | HKEx | ||
| 17.03. | LEE'S PHARM (00950): NOTICE OF BOARD MEETING | 5 | HKEx | ||
| 27.01. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR ADASUVE | - | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 114,42 | +0,60 % | Big Pharma sucht den nächsten Blockbuster - weshalb Zelltherapien wieder stärker in den Fokus rücken | ||
| ZOETIS | 66,14 | -0,21 % | Dividendenbekanntmachungen (20.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADENTRA INC CA00686A1084 0,16 CAD 0,0997 EUR BUERGERLICHES BRAUHAUS RAVENSBURG-LINDAU ... DE0005281000 - 10 EUR CATERPILLAR INC US1491231015 1... ► Artikel lesen | |
| SINOPHARM | 1,851 | -1,91 % | Dividendenbekanntmachungen (23.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADAMAS TRUST INC US6496048405 0,27 USD 0,2362 EUR AECON GROUP INC CA00762V1094 0,1925 CAD 0,1189 EUR AMPHENOL CORPORATION US0320951017 0... ► Artikel lesen | |
| CSPC PHARMA | 0,943 | -1,81 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PALIPERIDONE PALMITATE INJECTION RECEIVES MARKETING APPROVAL | ||
| WUXI BIOLOGICS | 4,270 | -1,39 % | WUXI BIO (02269): DATE OF BOARD MEETING | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 1,772 | 0,00 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL OF DRUG CLINICAL TRIAL OF A SUBSIDIARY | ||
| GEDEON RICHTER | 31,720 | -0,81 % | Gedeon Richter: Das "House of Hope" in Bamako leistet auch 2026 weiterhin lebenswichtige Hilfe für schutzbedürftige Frauen in Mali | BUDAPEST, UNGARN / ACCESS Newswire / 22. Juli 2026 / Das "Gedeon Richter House of Hope"-Zentrum in
Bamako, Mali, leistete auch in der ersten Hälfte des Jahres... ► Artikel lesen | |
| DR REDDYS | 10,200 | 0,00 % | Dividendenbekanntmachungen (24.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADRIANO CARE SOCIMI SA ES0105405007 - 0,1215 EUR ALEXANDERWERK AG DE000A37FTW0 - 0,5 EUR ARROWMARK FINANCIAL CORP US8617801043 0... ► Artikel lesen | |
| MEDIPHARM LABS | 0,046 | 0,00 % | MediPharm Labs Corp.: MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer's Disease and Dementia | Results presented by the LiBBY study team at the Alzheimer's Association International Conference ("AAIC") demonstrated statistically significant improvements in agitation symptoms compared with placebo.The... ► Artikel lesen | |
| ASPEN PHARMACARE | 8,000 | +5,26 % | Aspen Pharmacare erhält Zulassung für Ozempic-Generikum in Kanada | ||
| SHANGHAI PHARMACEUTICALS | 1,380 | +3,76 % | SH PHARMA (02607): UPDATE ON CONNECTED TRANSACTION PROPOSED PARTICIPATION IN THE ESTABLISHMENT OF THE SHANGHAI BIOMEDICAL PHASE II FUND | ||
| LUYE PHARMA | 0,230 | -0,86 % | LUYE PHARMA Completes Early Redemption of USD180 million Convertible Bonds Due 2028 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,091 | -8,12 % | Dividendenbekanntmachungen (30.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABACUS GROUP UTS AU0000291882 0,0212 AUD 0,0128 EUR ACADIA REALTY TRUST US0042391096 0,2 USD 0,175 EUR ACADIAN TIMBER CORP CA0042721005 0... ► Artikel lesen | |
| HANSOH PHARMACEUTICAL | 3,549 | -1,31 % | Hansoh Pharma: Phase III Trial For Ris-Rez Meets Primary Endpoint In China | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - GSK plc (GSK, GSK.L) licensor Hansoh Pharmaceutical Group announced that ARTEMIS-008, its phase III trial evaluating risvutatug rezetecan or Ris-Rez in patients... ► Artikel lesen | |
| CHINA RESOURCES PHARMACEUTICAL | 0,530 | -0,93 % | CHINARES PHARMA Subsidiary Completes Issuance of RMB1B Medium-term Notes at 1.53% Coupon Rate |